Comparative Effect of Nebivolol vs. Metoprolol on Insulin Sensitivity and Fibrinolytic Balance in Metabolic Syndrome.

Trial Profile

Comparative Effect of Nebivolol vs. Metoprolol on Insulin Sensitivity and Fibrinolytic Balance in Metabolic Syndrome.

Completed
Phase of Trial: Phase IV

Latest Information Update: 20 Dec 2016

At a glance

  • Drugs Nebivolol (Primary) ; Metoprolol
  • Indications Metabolic syndrome
  • Focus Therapeutic Use
  • Most Recent Events

    • 12 Feb 2012 Results published in Hypertension.
    • 06 Sep 2011 Actual end date June 2011 as reported by ClinicalTrials.gov
    • 06 Sep 2011 Status changed from recruiting to completed as reported by ClinicalTrials.gov.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top